在儿科患者的跨或跨肝接入后,使用可吸收的凝海绵鱼雷进行通道栓塞
Mert Bayramoğlu1, Yunus Emre Şentürk1, Enes Muhammed Cantürk1
1Koç University Hospital, Clinic of Radiology, İstanbul, Türkiye.
Diagnostic and interventional radiology (Ankara, Turkey)
|February 4, 2026
概括
可吸收凝海绵 (AGS) 鱼雷在儿科门静脉再通道后有效地关闭了通道,防止了显著的出血. 这种方法对年轻患者的安全和可控管道密封有希望.
科学领域:
- 干预性放射学 干预性放射学
- 儿科胃肠病学 儿科胃肠病学
- 血管外科 血管外科
背景情况:
- 儿科外肝门静脉阻塞 (EHPVO) 需要进行门静脉再通道化等干预措施.
- 这些手术后的通道管理对于预防诸如出血等并发症至关重要.
- 需要新的静血技术来提高儿科血管干预的安全性.
研究的目的:
- 评估使用可吸收凝海绵 (AGS) 鱼雷在儿科门静脉再通道化后通道关闭的可行性.
- 评估与AGS鱼雷通道关闭相关的早期术后出血结果.
- 在儿科EHPVO干预中描述通道关闭方法.
主要方法:
- 对18名儿科患者 (平均年龄为7岁) 的回顾性审查,这些患者接受了AGS鱼雷通道栓塞的门静脉再通道.
- 通过体和通过肝脏的通道 (5F-6F外) 进行分析,使用手术内未分离的肝素.
- 主要结局:24小时内临床显著的通道出血 (血红蛋白降低>2g/dL和腹腔内液体增加).
主要成果:
- 18名患者有28条通道 (13条跨,15条跨肝) 通过每条通道中位数为3个AGS鱼雷 (100%的成功率) 成功栓塞.
- 在患者或通道层面上,在手术后24小时内没有发生临床上显著的通道出血.
- 起初,轻微的周/周肝液收集很常见,但在随访超声波时没有增加.
结论:
- 关闭AGS鱼雷管道是一种可行且有效的方法,可以在儿科门静脉再通道化后预防显著出血.
- 该技术展示了使用可吸收材料的受控,分层的辅酶密封.
- 建议进行进一步的大型多中心研究,标准化终点,以验证这些发现.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
264
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
311
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
233
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
301
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
01:29Pulmonary Embolism I: Introduction
720
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
720
01:27Pulmonary Embolism III: Nursing Management
443
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
443